F C Koerner

Summary

Affiliation: Massachusetts General Hospital
Country: USA

Publications

  1. ncbi request reprint Papilloma and papillary carcinoma
    Frederick Koerner
    Pathology Service, Massachusetts General Hospital, James Homer Wright Laboratory of Pathology, Boston, Massachusetts 02114, USA
    Semin Diagn Pathol 27:13-30. 2010
  2. ncbi request reprint Epithelial proliferations of ductal type
    Frederick C Koerner
    James Homer Wright Pathology Laboratories, Massachusetts General Hospital and Harvard Medical School, 55 Fruit St, Boston, MA 02114, USA
    Semin Diagn Pathol 21:10-7. 2004
  3. ncbi request reprint Ovarian hormone receptors in human mammary stromal cells
    F Koerner
    James Homer Wright Laboratory of Pathology, Massachusetts General Hospital, Department of Pathology, Harvard Medical School, Boston, MA 02114, USA
    J Steroid Biochem Mol Biol 78:285-90. 2001
  4. ncbi request reprint Morphological observations regarding the origins of atypical cystic lobules (low-grade clinging carcinoma of flat type)
    F C Koerner
    Department of Pathology, Massachusetts General Hospital, Boston 02114, USA
    Virchows Arch 439:523-30. 2001
  5. ncbi request reprint A brief historical perspective on the pathology of the breast: from Cheatle to Azzopardi and beyond
    Frederick C Koerner
    James Homer Wright Pathology Laboratories, Massachusetts General Hospital and Harvard Medical School, 55 Fruit St, Boston, MA 02114, USA
    Semin Diagn Pathol 21:3-9. 2004
  6. ncbi request reprint Collagenous spherulosis: an ultrastructural study
    H M Maluf
    Department of Pathology, University of Tennessee, Memphis, USA
    Ultrastruct Pathol 22:239-48. 1998
  7. ncbi request reprint Atypical cystic lobules in patients with lobular neoplasia
    E Brogi
    Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
    Int J Surg Pathol 9:201-6. 2001
  8. ncbi request reprint pS2 expression and response to hormonal therapy in patients with advanced breast cancer
    L H Schwartz
    Department of Radiation Therapy, Massachusetts General Hospital, Harvard Medical School, Boston 02114
    Cancer Res 51:624-8. 1991
  9. ncbi request reprint Solid papillary carcinoma of breast: an ultrastructural study
    G R Dickersin
    Department of Pathology, Harvard Medical School, Massachusetts General Hospital, Boston 02114, USA
    Ultrastruct Pathol 21:153-61. 1997
  10. doi request reprint Development and validation of a model predictive of occult nipple involvement in women undergoing mastectomy
    J E Rusby
    Division of Surgical Oncology, Massachusetts General Hospital, Boston, Massachusetts 02114, USA
    Br J Surg 95:1356-61. 2008

Collaborators

Detail Information

Publications13

  1. ncbi request reprint Papilloma and papillary carcinoma
    Frederick Koerner
    Pathology Service, Massachusetts General Hospital, James Homer Wright Laboratory of Pathology, Boston, Massachusetts 02114, USA
    Semin Diagn Pathol 27:13-30. 2010
    ..This phenomenon complicates the recognition of invasion by many papillary carcinomas and has given rise to controversy about the nature of the lesion classically known as "intracystic papillary carcinoma."..
  2. ncbi request reprint Epithelial proliferations of ductal type
    Frederick C Koerner
    James Homer Wright Pathology Laboratories, Massachusetts General Hospital and Harvard Medical School, 55 Fruit St, Boston, MA 02114, USA
    Semin Diagn Pathol 21:10-7. 2004
    ..Current evidence does not support the belief that conventional ductal hyperplasia represents an obligate precursor to ductal carcinoma in situ...
  3. ncbi request reprint Ovarian hormone receptors in human mammary stromal cells
    F Koerner
    James Homer Wright Laboratory of Pathology, Massachusetts General Hospital, Department of Pathology, Harvard Medical School, Boston, MA 02114, USA
    J Steroid Biochem Mol Biol 78:285-90. 2001
    ..The findings also illustrate similarities in the organization of the rodent and human breasts and thereby suggest that regulation of the gland by ovarian hormones involves similar mechanisms in both species...
  4. ncbi request reprint Morphological observations regarding the origins of atypical cystic lobules (low-grade clinging carcinoma of flat type)
    F C Koerner
    Department of Pathology, Massachusetts General Hospital, Boston 02114, USA
    Virchows Arch 439:523-30. 2001
    ..Considering these observations, we ascribe the formation of atypical cystic lobules to the accumulation of atypical cells in pre-existing terminal duct-lobular units...
  5. ncbi request reprint A brief historical perspective on the pathology of the breast: from Cheatle to Azzopardi and beyond
    Frederick C Koerner
    James Homer Wright Pathology Laboratories, Massachusetts General Hospital and Harvard Medical School, 55 Fruit St, Boston, MA 02114, USA
    Semin Diagn Pathol 21:3-9. 2004
    ..With ever more sophistication and increasingly powerful techniques, this trend continues to this day...
  6. ncbi request reprint Collagenous spherulosis: an ultrastructural study
    H M Maluf
    Department of Pathology, University of Tennessee, Memphis, USA
    Ultrastruct Pathol 22:239-48. 1998
    ..The authors propose that spherules represent a peculiar form of stromal invagination that could be seen in a variety of breast lesions, rather than a form of intraductal hyperplasia...
  7. ncbi request reprint Atypical cystic lobules in patients with lobular neoplasia
    E Brogi
    Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
    Int J Surg Pathol 9:201-6. 2001
    ..The presence of ACLs in patients with LN might explain its increased risk for the development of ductal carcinomas and their bilateral distribution. Int J Surg Pathol 9(3):201-206, 2001..
  8. ncbi request reprint pS2 expression and response to hormonal therapy in patients with advanced breast cancer
    L H Schwartz
    Department of Radiation Therapy, Massachusetts General Hospital, Harvard Medical School, Boston 02114
    Cancer Res 51:624-8. 1991
    ..The odds of having a clinical response to hormonal therapy was greater for pS2-positive than for ER- or PgR-positive tumors. pS2 expression may define a subset of ER-positive tumors that are more likely to respond to hormonal treatment...
  9. ncbi request reprint Solid papillary carcinoma of breast: an ultrastructural study
    G R Dickersin
    Department of Pathology, Harvard Medical School, Massachusetts General Hospital, Boston 02114, USA
    Ultrastruct Pathol 21:153-61. 1997
    ....
  10. doi request reprint Development and validation of a model predictive of occult nipple involvement in women undergoing mastectomy
    J E Rusby
    Division of Surgical Oncology, Massachusetts General Hospital, Boston, Massachusetts 02114, USA
    Br J Surg 95:1356-61. 2008
    ..This prospective study aimed to build a predictive model using preoperative information to aid selection for nipple-sparing mastectomy...
  11. ncbi request reprint Mammographic appearance of ductal carcinoma in situ does not reliably predict histologic subtype
    P J Slanetz
    Department of Radiology, Beth Israel Deaconess Medical Center, Boston, Massachusetts 02215, USA
    Breast J 7:417-21. 2001
    ..A histologic grade of DCIS cannot accurately be determined prospectively based on the mammographic appearance of microcalcifications. However, if only a mass is present, this is more likely to represent well-differentiated DCIS...
  12. ncbi request reprint Noninvasive papillary proliferations
    Tetsunari Oyama
    Department of Tumor Pathology, Gunma University Graduate School of Medicine, Showa machi, Maebashi, Japan
    Semin Diagn Pathol 21:32-41. 2004
    ..Micropapillary ductal carcinoma in situ exhibits extreme dilatation of ducts and lobules, micropapillae varying in size and shape, lack of maturation, dishesion and necrosis, and cytological atypicality...
  13. ncbi request reprint Solid papillary ductal carcinoma in situ versus usual ductal hyperplasia in the breast: a potentially difficult distinction resolved by cytokeratin 5/6
    Joseph T Rabban
    Department of Pathology, University of California San Francisco, San Francisco, CA 94143, USA
    Hum Pathol 37:787-93. 2006
    ..Pathologists must guard against misinterpreting SP-DCIS as UDH in those cases in which the carcinoma cells engulf cytokeratin 5/6-expressing residual, native epithelial cells...